Bio-sight Capital names Koji Miyata as CEO, replacing Masayuki Tani
Reuters2026/08/21 04:47Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Bio-sight Capital named Koji Miyata as representative director, effective Aug. 20, 2026.
- Former CEO Masayuki Tani stepped down from the post.
- Executive director Nobuo Fukuda moved to an adviser role.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-sight Capital Inc published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bavarian Nordic raises FY2026 outlook, sees revenue about DKK 5.7 billion
Reuters•2026/08/21 05:44
Global Equities Roundup: Market Talk
Dow Jones•2026/08/21 05:42
Fed's Communication Shift Has Contributed to Higher Volatility -- Market Talk
Dow Jones•2026/08/21 05:37
